Table 6 Prevalence of glucose homeostasis abnormalities according to body composition categorised into 4 groups of fat distribution
Categories of fat distribution by clinical lipoatrophy and WC | Categories of fat distribution by FMR and WC | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
CLA- AP- | CLA-AP+ | CLA + AP- | CLA + AP+ | P | L- AP- | L-AP+ | L + AP- | L + AP+ | P | |
NG [n (%)] | 17 (56.7) | 27 (45.8) | 41 (58.6) | 22 (37.3) | 0.064 | 39 (61.9) | 32 (50.8) | 19 (51.4) | 17 (30.9) | 0.002 |
IFG [n (%)] | 1 (3.3) | 9 (15.3) | 4 (5.7) | 4 (6.8) | 0 (0.0) | 7 (11.1) | 5 (13.5) | 6 (10.9) | ||
IGT [n (%)] | 5 (16.7) | 16 (27.1) | 10 (14.3) | 18 (30.5) | 9 (14.3) | 17 (27.0) | 6 (16.2) | 17 (30.9) | ||
DM [n (%)] | 7 (23.3) | 7 (11.9) | 15 (21.4) | 15 (25.4) | 15 (23.8) | 7 (11.1) | 7 (18.9) | 15 (27.3) | ||